Physician profile
Robert R Cloud
NPI 1467440073
$670.65
in general payments reported to CMS, 2019-2025
12 companies · $76.82 in 2025
The $76.82 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $149 · 2021: $56.85 · 2022: $108 · 2023: $32.65 · 2025: $76.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $168.01 | 2019-2025 | Sutab |
| Pacira Pharmaceuticals Incorporated | $116.20 | 2019-2025 | Exparel |
| Thd America, INC. | $106.71 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $91.70 | 2019-2020 | |
| Axonics, INC. | $42.56 | 2022 | |
| Ferring Pharmaceuticals INC. | $34.82 | 2019 | |
| Integra Lifesciences Corporation | $24.03 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.02 | 2021 | |
| Caris Mpi, INC. | $19.83 | 2025 | Mi Cancer Seek |
| Novartis Pharmaceuticals Corporation | $17.60 | 2019 | |
| Ethicon US, LLC | $14.43 | 2023 | Echelon; Endopath |
| Medtronic, INC. | $12.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cloud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.